BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31987696)

  • 1. Detecting copy number alterations of oncogenes in cell-free DNA to monitor treatment response in acral and mucosal melanoma.
    Mikoshiba A; Ashida A; Sakaizawa K; Kiniwa Y; Okuyama R
    J Dermatol Sci; 2020 Mar; 97(3):172-178. PubMed ID: 31987696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCND1 copy number increase and cyclin D1 expression in acral melanoma: a comparative study of fluorescence in situ hybridization and immunohistochemistry in a Chinese cohort.
    Liu J; Yu W; Gao F; Qi S; Du J; Ma X; Zhang Y; Zheng J; Su J
    Diagn Pathol; 2021 Jul; 16(1):60. PubMed ID: 34225728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIT amplification and gene mutations in acral/mucosal melanoma in Korea.
    Yun J; Lee J; Jang J; Lee EJ; Jang KT; Kim JH; Kim KM
    APMIS; 2011 Jun; 119(6):330-5. PubMed ID: 21569090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy.
    Xu L; Cheng Z; Cui C; Wu X; Yu H; Guo J; Kong Y
    J Transl Med; 2019 Jul; 17(1):245. PubMed ID: 31358010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct sets of genetic alterations in melanoma.
    Curtin JA; Fridlyand J; Kageshita T; Patel HN; Busam KJ; Kutzner H; Cho KH; Aiba S; Bröcker EB; LeBoit PE; Pinkel D; Bastian BC
    N Engl J Med; 2005 Nov; 353(20):2135-47. PubMed ID: 16291983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomic site-specific patterns of gene copy number gains in skin, mucosal, and uveal melanomas detected by fluorescence in situ hybridization.
    Glatz-Krieger K; Pache M; Tapia C; Fuchs A; Savic S; Glatz D; Mihatsch M; Meyer P
    Virchows Arch; 2006 Sep; 449(3):328-33. PubMed ID: 16523260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale analysis of KIT aberrations in Chinese patients with melanoma.
    Kong Y; Si L; Zhu Y; Xu X; Corless CL; Flaherty KT; Li L; Li H; Sheng X; Cui C; Chi Z; Li S; Han M; Mao L; Lu A; Guo J
    Clin Cancer Res; 2011 Apr; 17(7):1684-91. PubMed ID: 21325067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.
    Hodi FS; Corless CL; Giobbie-Hurder A; Fletcher JA; Zhu M; Marino-Enriquez A; Friedlander P; Gonzalez R; Weber JS; Gajewski TF; O'Day SJ; Kim KB; Lawrence D; Flaherty KT; Luke JJ; Collichio FA; Ernstoff MS; Heinrich MC; Beadling C; Zukotynski KA; Yap JT; Van den Abbeele AD; Demetri GD; Fisher DE
    J Clin Oncol; 2013 Sep; 31(26):3182-90. PubMed ID: 23775962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIT gene mutations and copy number in melanoma subtypes.
    Beadling C; Jacobson-Dunlop E; Hodi FS; Le C; Warrick A; Patterson J; Town A; Harlow A; Cruz F; Azar S; Rubin BP; Muller S; West R; Heinrich MC; Corless CL
    Clin Cancer Res; 2008 Nov; 14(21):6821-8. PubMed ID: 18980976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type.
    Torres-Cabala CA; Wang WL; Trent J; Yang D; Chen S; Galbincea J; Kim KB; Woodman S; Davies M; Plaza JA; Nash JW; Prieto VG; Lazar AJ; Ivan D
    Mod Pathol; 2009 Nov; 22(11):1446-56. PubMed ID: 19718013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TERT and AURKA gene copy number gains enhance the detection of acral lentiginous melanomas by fluorescence in situ hybridization.
    Diaz A; Puig-Butillé JA; Valera A; Muñoz C; Costa D; Garcia-Herrera A; Carrera C; Sole F; Malvehy J; Puig S; Alos L
    J Mol Diagn; 2014 Mar; 16(2):198-206. PubMed ID: 24374110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas.
    Ashida A; Takata M; Murata H; Kido K; Saida T
    Int J Cancer; 2009 Feb; 124(4):862-8. PubMed ID: 19035443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma.
    Gangadhar TC; Savitch SL; Yee SS; Xu W; Huang AC; Harmon S; Lieberman DB; Soucier D; Fan R; Black TA; Morrissette JJD; Salathia N; Waters J; Zhang S; Toung J; van Hummelen P; Fan JB; Xu X; Amaravadi RK; Schuchter LM; Karakousis GC; Hwang WT; Carpenter EL
    Pigment Cell Melanoma Res; 2018 Jan; 31(1):73-81. PubMed ID: 28786531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy.
    Kong Y; Sheng X; Wu X; Yan J; Ma M; Yu J; Si L; Chi Z; Cui C; Dai J; Li Y; Yu H; Xu T; Tang H; Tang B; Mao L; Lian B; Wang X; Yan X; Li S; Guo J
    Clin Cancer Res; 2017 Nov; 23(22):6946-6957. PubMed ID: 28830923
    [No Abstract]   [Full Text] [Related]  

  • 15. Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma.
    Hou JY; Baptiste C; Hombalegowda RB; Tergas AI; Feldman R; Jones NL; Chatterjee-Paer S; Bus-Kwolfski A; Wright JD; Burke WM
    Cancer; 2017 Apr; 123(8):1333-1344. PubMed ID: 28026870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIT gene mutations and patterns of protein expression in mucosal and acral melanoma.
    Abu-Abed S; Pennell N; Petrella T; Wright F; Seth A; Hanna W
    J Cutan Med Surg; 2012; 16(2):135-42. PubMed ID: 22513068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Kit inhibitors for unresectable or metastatic mucosal, acral or chronically sun-damaged melanoma: a systematic review and one-arm meta-analysis.
    Steeb T; Wessely A; Petzold A; Kohl C; Erdmann M; Berking C; Heppt MV
    Eur J Cancer; 2021 Nov; 157():348-357. PubMed ID: 34562816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Tumour DNA for Monitoring Treatment Response to Anti-PD-1 Immunotherapy in Melanoma Patients.
    Ashida A; Sakaizawa K; Uhara H; Okuyama R
    Acta Derm Venereol; 2017 Nov; 97(10):1212-1218. PubMed ID: 28681063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Genomic Profiling of Acral Melanoma.
    Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
    J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure.
    Haugh AM; Zhang B; Quan VL; Garfield EM; Bubley JA; Kudalkar E; Verzi AE; Walton K; VandenBoom T; Merkel EA; Lee CY; Tan T; Isales MC; Kong BY; Wenzel AT; Bunick CG; Choi J; Sosman J; Gerami P
    J Invest Dermatol; 2018 Feb; 138(2):384-393. PubMed ID: 28870692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.